Breast cancers with high PR-A/PR-B ratios metastatic growth was inhibited by antiprogestins, and the metastatic growth of breast cancers with low PR-A/PR-B ratios was inhibited with progestins [22, 23]. This evidence concerns the gene S100A6 and breast carcinoma.